Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
The offering involves the purchase of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Approximately $3.9 million before expenses.
Closing Date
Expected on August 15, 2025.
- The offering is made through an effective shelf registration statement on Form S-3.
- Maxim Group LLC is the sole placement agent for the offering.
This securities purchase agreement represents a significant step for Scienture Holdings, Inc. in raising funds for its pharmaceutical operations.